TPG seals Russia’s largest buyout deal
TPG's $800m pure equity stake in the country's biggest pharmaceutical distributor should allow the global buyout firm to tap into the fast-growing Russian market.
12 January 2013•2 mins read
TPG's $800m pure equity stake in the country's biggest pharmaceutical distributor should allow the global buyout firm to tap into the fast-growing Russian market.
